Daily SPAC Update – Jan 29, 2024

by | Jan 29, 2024

Daily SPAC Update for Jan 29, 2024. Extension votes for APTM, ONYX, CSTAF. SEPA + SANUWAVE Health deal vote. List of this week’s SPAC votes.

Boardroom Alpha SPAC Resources
Full SPAC Listing
SPAC SEC Filings
Boardroom Alpha SPAC Intelligence Platform (7-Day Trial)

Daily SPAC Update

TODAY’S EXTENSION VOTES
APTM – ALPHA PARTNERS TECHNOLOGY MERGER CORP * extend from July 30, 2024 to Jan 30, 2025
CSTAF – CONSTELLATION ACQUISITION CORP I * 12 monthly extensions to Jan 29, 2025
ONYX – ONYX ACQUISITION CO I * extend February 7, 2024 to November 5, 2024

MERGER VOTES
SEPA + SANUWAVE Health, Inc.

OTHER SPAC NEWS
SZZL – SIZZLE ACQUISITION CORP * Deal vote delayed to Feb 6
JWSM – JAWS MUSTANG ACQUISITION CORP * Extension vote adjourned
PUCK – GOAL ACQUISITIONS CORP * Extension Vote Set: Feb 07, 2024 * trust $10.75
CVII – CHURCHILL CAPITAL CORP VII * New investor deck
XFIN – EXCELFIN ACQUISITION CORP * New investor deck

THIS WEEK’S EXTENSION VOTES
APTM – ALPHA PARTNERS TECHNOLOGY MERGER CORP * extend from July 30, 2024 to Jan 30, 2025
ARRW – ARROWROOT ACQUISITION CORP * extend to Aug 7, 2024
BLUA – BLUERIVER ACQUISITION CORP *  extend to 3 monthly options to May 2, 2024
CETU – CETUS CAPITAL ACQUISITION CORP * 6 monthly options to Aug 3, 2024
CSTAF – CONSTELLATION ACQUISITION CORP I * 12 monthly extensions to Jan 29, 2025
JWSM – JAWS MUSTANG ACQUISITION CORP * extend to Feb 4, 2025
KRNL – KERNEL GROUP HOLDINGS INC * extend 6 monthly options to Aug 5, 2024
MARX – MARS ACQUISITION CORP * extend to Nov 16, 2024
NFYS – ENPHYS ACQUISITION CORP * extend to June 8, 2024
NRAC – NORTHERN REVIVAL ACQUISITION CORP * vote Jan 30, 2024 -> extend to Aug 4, 2024
ONYX – ONYX ACQUISITION CO I *  extend February 7, 2024 to November 5, 2024

YESTERDAY’S TOP SPAC GAINERS
18.40% ~ $ 5.02 | ATAK – Aurora Technology Acquisition Corp. (Announced)
9.91% ~ $ 11.53 | CETU – Cetus Capital Acquisition Corp. (Announced)
9.37% ~ $ 38.18 | DWAC – Digital World Acquisition Corp. (Announced)
6.64% ~ $ 5.30 | DECA – Denali Capital Acquisition Corp. (Announced)
2.29% ~ $ 11.59 | ADRT – Ault Disruptive Technologies Corp (Pre-Deal)

YESTERDAY’S TOP SPAC LOSERS
-31.40% ~ $ 7.58 | LGST – Semper Paratus Acquisition Corp (Announced)
-17.83% ~ $ 7.69 | DMAQ – Deep Medicine Acquisition Corp. (Announced)
-13.95% ~ $ 9.50 | SZZL – Sizzle Acquisition Corp. (Announced)
-8.63% ~ $ 11.75 | OTEC – OceanTech Acquisitions I Corp. (Announced)
-8.44% ~ $ 8.24 | NUBI – Nubia Brand International Corp. (Announced)

ICYMI: SEC APPROVES FINAL RULES

For most, the SPAC boom is long-dead and was unlikely to ever return to the levels of irrational exuberance seen during peak times. Still, the SEC has long wanted to layer on additional regulation to ensure that it doesn’t happen. On Jan 24 the SEC commission, chaired by Gary Gensler, voted 3-2 to adopt the new rules which will make SPACs feel a lot more like traditional IPOs. For more on the new rules and the market’s reaction, below are some good reads.

Recent Analysis

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.